“We used to think we could just give a drug and patients should get better,” Jain said. “Now, we have tools to measure the nuances that make a difference. PET could be used to study other antibiotics and also allow precision medicine approaches in resource-rich settings, such as the U.S. for other serious infections including MRSA (methicillin-resistant Staphylococcus aureus).” {read more here}

In the diagnosis of Alzheimer’s disease and the search for effective treatments, tau tangles in the brain have joined amyloid build-up as markers of the disease and potential therapy targets. In the December issue of The Journal of Nuclear Medicine, the featured article of the month reports on the identification of a promising second-generation positron emission tomography (PET) tracer for imaging and measuring tau pathology. {read more here}

To combat poor image results from patient motion in cardiac PET scans, researchers from the U.S. and U.K. have developed an automated retrospective image reconstruction method that greatly reduces the unwanted effects, according to a study published online November 15 in the Journal of Nuclear Medicine. {read more here}